SCHEMBL8043459

SCHEMBL8043459

NS(=O)(=O)c1ccc(F)cc1.[KH]

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.72
PTGS2 P35354 8/20 0.67
PTGS1 P23219 7/20 0.67
CA2 P00918 9/20 0.64
CA1 P00915 8/20 0.64
CA9 Q16790 8/20 0.62
CA12 O43570 6/20 0.62
CA7 P43166 4/20 0.62
CA4 P22748 3/20 0.62
MAOA P21397 2/20 0.62
MAOB P27338 1/20 0.60
CA14 Q9ULX7 2/20 0.56
USP2 O75604 1/20 0.56
TSHR P16473 1/20 0.56
CA6 P23280 1/20 0.56
CA5A P35218 1/20 0.56
CA13 Q8N1Q1 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
AGO2 Q9UKV8 1/20 0.56
CA5B Q9Y2D0 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL283919 0.97 SOS1 (0.75) SOS1PTGS2PTGS1CA2CA1
SCHEMBL31527705 0.97 SOS1 (0.75) SOS1PTGS2PTGS1CA2CA1
Iodide SCHEMBL28540305 0.95 SOS1 (0.72) SOS1PTGS2PTGS1CA2CA1
Hydrochloric Acid SCHEMBL29876112 0.95 SOS1 (0.72) SOS1PTGS2PTGS1CA2CA1
SCHEMBL1430142 0.90 CA2 (0.76) SOS1PTGS2PTGS1CA2CA1
SCHEMBL28385356 0.88 SOS1 (0.64) SOS1PTGS2PTGS1CA2CA1
Sulfanilamide SCHEMBL27994963 0.88 CA2 (0.77) SOS1PTGS2PTGS1CA2CA1
SCHEMBL27510169 0.84 SOS1 (1.00) SOS1PTGS2PTGS1CA2CA1
SCHEMBL202948 0.83 CA2 (0.81) CA2CA1CA9CA12CA7
Benzenesulfonamide SCHEMBL28328141 0.83 PTGS2 (0.65) SOS1PTGS2PTGS1CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6030976-A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE, PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, MEMORY DISORDERS, PARKINSON'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS AND HUNTINGTON'S DISEASE HOFFMAN-LA ROCHE INC. (US) 2000-02-29 US disclosed
US-5998665-A THERAPY FOR NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-12-07 US disclosed
US-5939451-A INDOL-4-YL-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-17 US disclosed
US-5932599-A 4-AMINO-N-(PYRIDINYL-4-YL)-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-03 US disclosed